A study led by Aaron Hobbs, Ph.D., and Rachel Burge, Ph.D., at MUSC Hollings Cancer Center, reveals why a specific gene ...

The experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, ...

Scientists at Duke-NUS Medical School and the National University Health System (NUHS), together with an international team ...

New research reveals that certain brain tumors may originate silently within normal brain cells long before a tumor forms.

Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...

Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

The American Cancer Society estimates that over 80,000 individuals will be diagnosed with bladder cancer this year.

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

The FDA has accepted a New Drug Application (NDA) for Celcuity’s gedatolisib in hormone receptor positive (HR+), human ...

More than 70% of people diagnosed with cancer in the United States now survive for five years or more, a milestone experts ...

Duke-NUS and NUHS scientists uncover a complex web of genetic, age-related and microbial factors that increase the risk of stomach cancer. Age-related blood cell mutations may trigger early changes in ...